 |
Code of Federal Regulations (Last Updated: May 6, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter D - Drugs for Human Use |
|
|
Part 433 - EXEMPTIONS FROM ANTIBIOTIC CERTIFICATION AND LABELING REQUIREMENTS |
| Subpart A - General Provisions |
| § 433.1 - Exemption of antibiotic drugs for human use from batch certification requirements. |
| § 433.2 - Conditions on the effectiveness of exemptions of antibiotic drugs for human use from batch certification requirements. |
| § 433.3 - Assay requirements for antibiotic drugs exempted from certification. |
| Subpart B - Exemptions for Which an Application or Notice Is Required |
| § 433.12 - Exemption for labeling. |
| § 433.13 - Exemption for manufacturing use. |
| § 433.14 - Exemption for storage. |
| § 433.15 - Exemption for processing. |
| § 433.16 - Exemption for repacking. |
| § 433.17 - Exemption for investigational use. |
| Subpart C - Specific Use Exemptions |
| § 433.20 - Antibiotic drugs for isolation and differentiation of microorganisms in clinical use. |
| § 433.21 - Antibiotics for diagnostic use. |
| § 433.22 - Biologic drugs that contain antibiotics as a preservative. |
| § 433.23 - Microbiological culture media containing antibiotics. |
| § 433.24 - Exemption of antibiotic drugs for use in teaching, law enforcement, research, and analysis. |
| § 433.25 - [Reserved] |
| § 433.26 - Neomycin sulfate ointment intended for hypersensitivity testing. |
| Subpart D - Records and Reports |
| § 433.30 - Records retention. |